Pacira | PCRX - PE Price to Earnings

Stock Price
22.64
Daily Change
-0.89 -3.78%
Monthly
-5.11%
Yearly
-12.45%
Q2 Forecast
22.18

Pacira reported 38.58 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Astellas Pharma 15.48 8.16 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Cara Therapeutics 27.77 117.09 Sep/2021
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 24.53 0.91 Mar/2026
Ligand Pharmaceuticals 56.5 26.8 Mar/2026
Novo Nordisk 12.78 0.01 Dec/2025
Pacira 38.58 14.1 Mar/2026
Perrigo 27.45 31.51 Mar/2026
Pfizer 9.32 5.16 Mar/2026
Supernus Pharmaceuticals 44.21 66.17 Mar/2026
Teva Pharmaceutical Industries 10.07 0.04 Mar/2026
Xoma 52.12 3.09 Sep/2022
Zoetis 18.8 1.62 Mar/2026